Amado Rafael
SEC-identified person · CIK 1662119 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zai Lab Ltd ZLAB | See Remarks | filed 2023 - 2026 |
| Poseida Therapeutics, Inc. PSTX | Director | filed 2023 - 2025 |
| Allogene Therapeutics, Inc. ALLO | EVP of R&D and CMO | filed 2019 - 2022 |
| Adaptimmune Therapeutics PLC ADAP] | President, R&D | filed 2016 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.